COVID-19 Vaccine-Associated Lymphadenopathy Mimicking Regrowth of Axillary Lymph Node Metastasis of Lung Adenocarcinoma.
COVID-19 vaccination
axillary lymphadenopathy
case report
lung cancer
Journal
Acta medica Okayama
ISSN: 0386-300X
Titre abrégé: Acta Med Okayama
Pays: Japan
ID NLM: 0417611
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
entrez:
10
11
2022
pubmed:
11
11
2022
medline:
15
11
2022
Statut:
ppublish
Résumé
We encountered a woman with re-enlarged axillary lymph nodes during a computed tomography (CT) scan for surveillance of lung adenocarcinoma with axillary lymph node metastasis at the initial diagnosis that had shrunk with standard chemotherapy. We first suspected cancer recurrence and considered a change in the chemotherapeutic regimen. However, after careful history taking regarding the timing of her Coronavirus Disease 2019 (COVID-19) vaccination, and subsequent careful, close follow-up, radiological shrinkage suggested a strictly benign cause. Especially in lung cancer with a medical history of axillary lymph node involvement, cliniciansshould be aware that vaccine-associated lymphadenopathy can mimic cancer recurrence and sometimesprompt serious misjudgment regarding a current treatment course and strategy.
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
593-596Déclaration de conflit d'intérêts
No potential conflict of interest relevant to this article was reported.
Références
Prieto PA, Mannava K and Sahasrabudhe DM: COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma. Lancet Oncol (2021) 22: e281.
Satoh H, Ishikawa H, Kagohashi K, Kurishima K and Sekizawa K: Axillary lymph node metastasis in lung cancer. Med Oncol (2009) 26: 147-150.
Üstün F, Tokuc B, Tastekin E and Durmuş Altun G: Tumor characteristics of lung cancer in predicting axillary lymph node metastases. Características tumorales del cáncer de pulmón para predecir metástasis en los ganglios axilares. Rev Esp Med Nucl Imagen Mol (Engl Ed) (2019) 38: 80-86.
Lam DL and Flanagan MR: Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer. JAMA (2022) 327: 175-176.
Panagiotidis E, Exarhos D, Housianakou I, Bournazos A and Datseris I: FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1). Eur Radiol (2010) 20: 1251-1253.
Barouni AS, Augusto C, Queiroz MV, Lopes MT and Zanini MS, Salas CE: BCG lymphadenopathy detected in a BCG-vaccinated infant. Braz J Med Biol Res (2004) 37: 697-700.
Pereira MP, Flores P and Neto AS: Neck and supraclavicular lymphadenopathy secondary to 9-valent human papillomavirus vaccination. BMJ Case Rep (2019) 12: e231582. Published 2019 Nov
Cohen D, Krauthammer SH, Wolf I and Even-Sapir E: Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F] FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging. (2021) 48: 1854-1863.
Lehman CD, D'Alessandro HA, Mendoza DP, Succi MD, Kambadakone A and Lamb LR: Unilateral lymphadenopathy after COVID-19 vaccination: A practical management plan for radiologists across specialties. J Am Coll Radiol (2021) 18: 843-852.
Becker AS, Perez-Johnston R, Chikarmane SA, Chen MM, El Homsi M, Feigin KN, Gallagher KM, Hanna EY, Hicks M, Ilica AT, Mayer EL, Shinagare AB, Yeh R, Mayerhoefer ME, Hricak H and Vargas HA: Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: Radiology scientific expert panel. Radiology (2021) 300: E323-E327.